Shionogi Drug Patent Portfolio
Shionogi owns 6 orange book drugs protected by 24 US patents with Radicava having the least patent protection, holding only 1 patent. And Radicava Ors with maximum patent protection, holding 12 patents. Given below is the list of Shionogi's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12194025 | Pharmaceutical composition for oral administration of edaravone and method of administering same | 12 Nov, 2041 | Active |
| US12310946 | Pharmaceutical composition for oral administration of edaravone and method of administering same | 12 Nov, 2041 | Active |
| US12478611 | Pharmaceutical Composition For Oral Administration Of Edaravone And Method Of Administering Same | 12 Nov, 2041 | Active |
| US12527769 | Pharmaceutical Composition For Oral Administration Of Edaravone And Method Of Administering Same | 12 Nov, 2041 | Active |
| US12569469 | Pharmaceutical Composition For Oral Administration Of Edaravone And Method Of Administering Same | 12 Nov, 2041 | Active |
| US10987341 | Edaravone suspension for oral administration | 01 Nov, 2039 | Active |
| US11241416 | Edaravone suspension for oral administration | 01 Nov, 2039 | Active |
| US11478450 | Edaravone suspension for oral administration | 01 Nov, 2039 | Active |
| US11826352 | Edaravone suspension for oral administration | 01 Nov, 2039 | Active |
| US11957660 | Edaravone suspension for oral administration | 01 Nov, 2039 | Active |
| US12285409 | Edaravone suspension for oral administration | 01 Nov, 2039 | Active |
| US12599586 | Edaravone Suspension For Oral Administration | 01 Nov, 2039 | Active |
| US10004750 | Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof | 03 Sep, 2035 | Active |
| US9949982 | Preparation containing cephalosporin having a catechol moiety | 03 Sep, 2035 | Active |
| US9238657 | Cephalosporin having catechol group | 14 Nov, 2033 | Active |
| US7294342 | Ectoparasite asphyxiator compositions and methods for their application | 19 May, 2024 | Expired |
| US6793931 | Ectoparasite asphyxiator compositions and methods for their applications | 11 Jul, 2022 | Expired |
| US8247402 | Crystal form of pyrrolidylthiocarbapenem derivative | 30 Mar, 2021 | Expired |
| US6933310 | Therapeutic agent for amyotrophic lateral sclerosis (ALS) | 13 Nov, 2020 | Expired |
| US6106861 | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth | 05 Dec, 2017 | Expired |
| US5858383 | Methods and compositions for topical treatment of ectoparasites | 11 Aug, 2017 | Expired |
| US6139859 | Methods and compositions for topical treatment of ectoparasites | 11 Aug, 2017 | Expired |
| US5317016 | Pyrrolidylthiocarbapenem derivative | 05 Jun, 2015 | Expired |
| US5464632 | Rapidly disintegratable multiparticular tablet | 22 Mar, 2013 | Expired |
Latest Legal Activities on Shionogi's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Shionogi.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification | 13 Nov, 2025 | US12478611 |
| Issue Notification Mailed | 12 Nov, 2025 | US12478611 |
| Dispatch to FDC | 28 Oct, 2025 | US12478611 |
| Application Is Considered Ready for Issue | 28 Oct, 2025 | US12478611 |
| Issue Fee Payment Received | 27 Oct, 2025 | US12478611 |
| Issue Fee Payment Verified | 27 Oct, 2025 | US12478611 |
| Email Notification | 08 Oct, 2025 | US12527769 |
| Mailing Corrected Notice of Allowability | 08 Oct, 2025 | US12527769 |
| Printer Rush- No mailing | 08 Oct, 2025 | US12478611 |
| Information Disclosure Statement considered | 08 Oct, 2025 | US12478611 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 08 Oct, 2025 | US9949982 |
| Pubs Case Remand to TC | 07 Oct, 2025 | US12478611 |
| Corrected Notice of Allowability | 06 Oct, 2025 | US12527769 |
| Information Disclosure Statement considered | 06 Oct, 2025 | US12527769 |
| Pubs Case Remand to TC | 02 Oct, 2025 | US12527769 |
Shionogi's Family Patents
Shionogi Drug List
Given below is the complete list of Shionogi's drugs and the patents protecting them.
1. Doribax
Doribax is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8247402 | Crystal form of pyrrolidylthiocarbapenem derivative |
30 Mar, 2021
(5 years ago)
| Expired |
| US5317016 | Pyrrolidylthiocarbapenem derivative |
05 Jun, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doribax's drug page
2. Fetroja
Fetroja is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10004750 | Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof |
03 Sep, 2035
(9 years from now)
| Active |
| US9949982 | Preparation containing cephalosporin having a catechol moiety |
03 Sep, 2035
(9 years from now)
| Active |
| US9238657 | Cephalosporin having catechol group |
14 Nov, 2033
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fetroja's drug page
3. Radicava
Radicava is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6933310 | Therapeutic agent for amyotrophic lateral sclerosis (ALS) |
13 Nov, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Radicava's drug page
4. Radicava Ors
Radicava Ors is protected by 12 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12194025 | Pharmaceutical composition for oral administration of edaravone and method of administering same |
12 Nov, 2041
(15 years from now)
| Active |
| US12310946 | Pharmaceutical composition for oral administration of edaravone and method of administering same |
12 Nov, 2041
(15 years from now)
| Active |
| US12478611 | Pharmaceutical Composition For Oral Administration Of Edaravone And Method Of Administering Same |
12 Nov, 2041
(15 years from now)
| Active |
| US12527769 | Pharmaceutical Composition For Oral Administration Of Edaravone And Method Of Administering Same |
12 Nov, 2041
(15 years from now)
| Active |
| US12569469 | Pharmaceutical Composition For Oral Administration Of Edaravone And Method Of Administering Same |
12 Nov, 2041
(15 years from now)
| Active |
| US10987341 | Edaravone suspension for oral administration |
01 Nov, 2039
(13 years from now)
| Active |
| US11241416 | Edaravone suspension for oral administration |
01 Nov, 2039
(13 years from now)
| Active |
| US11478450 | Edaravone suspension for oral administration |
01 Nov, 2039
(13 years from now)
| Active |
| US11826352 | Edaravone suspension for oral administration |
01 Nov, 2039
(13 years from now)
| Active |
| US11957660 | Edaravone suspension for oral administration |
01 Nov, 2039
(13 years from now)
| Active |
| US12285409 | Edaravone suspension for oral administration |
01 Nov, 2039
(13 years from now)
| Active |
| US12599586 | Edaravone Suspension For Oral Administration |
01 Nov, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Radicava Ors's drug page
5. Rybix Odt
Rybix Odt is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6106861 | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth |
05 Dec, 2017
(8 years ago)
| Expired |
| US5464632 | Rapidly disintegratable multiparticular tablet |
22 Mar, 2013
(13 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rybix Odt's drug page
Explore Our Curated Drug Screens
6. Ulesfia
Ulesfia is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7294342 | Ectoparasite asphyxiator compositions and methods for their application |
19 May, 2024
(1 year, 11 months ago)
| Expired |
| US6793931 | Ectoparasite asphyxiator compositions and methods for their applications |
11 Jul, 2022
(3 years ago)
| Expired |
| US5858383 | Methods and compositions for topical treatment of ectoparasites |
11 Aug, 2017
(8 years ago)
| Expired |
| US6139859 | Methods and compositions for topical treatment of ectoparasites |
11 Aug, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ulesfia's drug page